Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11452]

Some CRISPR screens may be missing cancer drug targets

Some CRISPR screens may be missing cancer drug targets

FDA approves durvalumab with chemotherapy for mismatch repair deficient primary advanced or recurrent endometrial cancer

FDA approves durvalumab with chemotherapy for mismatch repair deficient primary advanced or recurrent endometrial...

Scientists discover how the physics of colon cancer cells contributes to metastasis

Scientists discover how the physics of colon cancer cells contributes to metastasis

Reinvigorating exhausted immune cells reveals potential therapy target for cancer

Reinvigorating exhausted immune cells reveals potential therapy target for cancer

FDA grants accelerated approval to repotrectinib for adult and paediatric patients with NTRK gene fusion-positive solid tumours

FDA grants accelerated approval to repotrectinib for adult and paediatric patients with NTRK gene fusion-positive...

CAR T cell therapy for advanced prostate cancer demonstrates positive results in phase 1 clinical trial

CAR T cell therapy for advanced prostate cancer demonstrates positive results in phase 1 clinical trial

$Trametinib shows promise for children with relapsed or refractory JMML$

Trametinib shows promise for children with relapsed or refractory JMML

Obesity-cancer connection discovery suggests strategies for improving immunotherapy

Obesity-cancer connection discovery suggests strategies for improving immunotherapy

Risk of secondary cancers after CAR-T cell therapy low, according to large study

Risk of secondary cancers after CAR-T cell therapy low, according to large study

Inherited genetic factors may predict the pattern of X chromosome loss in older women

Inherited genetic factors may predict the pattern of X chromosome loss in older women

More from ecancer